Skip to main content
. 2023 Jul 3;37(4):1894–1900. doi: 10.21873/invivo.13283

Table II. Rate of dysgeusia onset based on the chemotherapy regimens and drugs.

graphic file with name in_vivo-37-1896-i0001.jpg

S-1: Tegafur/gimeracil/oteracil potassium; CPT-11(IRI): irinotecan hydrochloride hydrate; 5-FU: 5-fluorouracil; LV: levofolinate calcium; GEM: gemcitabine hydrochloride; CDDP: cisplatin; PTX: paclitaxel; LOHP: oxaliplatin.